Cnb Bank Gsk PLC Transaction History

Cnb Bank

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 29, 2021	SELL	$36.52 - $41.46 $5,478 - $6,219	-150 Reduced 30.61%	340 $14,000
Q1 2021 May 03, 2021	BUY	$34.27 - $40.01 $5,140 - $6,001	150 Added 44.12%	490 $17,000
Q3 2020 Oct 26, 2020	SELL	$38.11 - $42.99 $2,782 - $3,138	-73 Reduced 17.68%	340 $13,000
Q2 2020 Jul 14, 2020	SELL	$37.87 - $43.58 $13,898 - $15,993	-367 Reduced 47.05%	413 $17,000
Q1 2020 May 13, 2020	BUY	$32.47 - $48.83 $7,305 - $10,986	225 Added 40.54%	780 $30,000
Q2 2019 Aug 14, 2019	BUY	$39.4 - $42.7 $5,594 - $6,063	142 Added 34.38%	555 $22,000
Q1 2019 Apr 29, 2019	BUY	$38.57 - $42.69 $6,364 - $7,043	165 Added 66.53%	413 $17,000
Q4 2017 Feb 20, 2018	BUY	$35.34 - $41.9 $8,764 - $10,391	248	248 $9,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Cnb Bank, based on Form 13F filings with the SEC.

Stay updated on Cnb Bank with notifications on news.